{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:24:18Z","timestamp":1778999058381,"version":"3.51.4"},"reference-count":34,"publisher":"Microbiology Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11,1]]},"abstract":"<jats:p>\n                    From 1997 to 2007, the Laboratory of Enteric Pathogens (LEP), Health Protection Agency, UK, received sera from 2148 patients for testing for antibodies to the LPS of verocytotoxin-producing\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    (VTEC) O157. A total of 676 (31.5\u200a%) sera had antibodies binding the LPS of\n                    <jats:italic>E. coli<\/jats:italic>\n                    O157 and the majority of patients were below the age of 10 years, a trend observed for both males and females. Antibody-positive patients had haemolytic uraemic syndrome (HUS) in 79.3\u200a% of cases and most of these presented with the atypical (D\u2212) form of HUS. Nine patients were shown to have antibodies to the LPS of\n                    <jats:italic>E. coli<\/jats:italic>\n                    belonging to serogroups O26 (4), O103 (2), O111 (1) and O145 (2) and one patient had antibodies to the somatic antigens of both\n                    <jats:italic>E. coli<\/jats:italic>\n                    O26 and O103. The serodiagnosis of infections with\n                    <jats:italic>E. coli<\/jats:italic>\n                    O157 and other VTEC continues to be an important adjunct to bacteriology. Where clinicians suspect the involvement of a VTEC in disease, patients' sera should be submitted to the LEP for analysis without delay.\n                  <\/jats:p>","DOI":"10.1099\/jmm.0.2008\/003632-0","type":"journal-article","created":{"date-parts":[[2008,10,16]],"date-time":"2008-10-16T15:24:31Z","timestamp":1224170671000},"page":"1389-1393","source":"Crossref","is-referenced-by-count":21,"title":["Human infections with verocytotoxin-producing Escherichia coli O157 \u2013 10 years of E. coli O157 serodiagnosis"],"prefix":"10.1099","volume":"57","author":[{"given":"Henrik","family":"Chart","sequence":"first","affiliation":[{"name":"Laboratory of Enteric Pathogens, Department of Gastrointestinal, Emerging and Zoonotic Infections, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Cheasty","sequence":"additional","affiliation":[{"name":"Laboratory of Enteric Pathogens, Department of Gastrointestinal, Emerging and Zoonotic Infections, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1128\/IAI.68.3.1116-1124.2000","article-title":"Distribution of core oligosaccharide types in lipopolysaccharides from Escherichia coli","volume":"68","author":"Amor","year":"2000","journal-title":"Infect Immun"},{"key":"R2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0950268800068102","article-title":"The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study","volume":"110","author":"Bitzan","year":"1993","journal-title":"Epidemiol Infect"},{"key":"R3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1023\/A:1008928822352","article-title":"Clinical significance of Verocytotoxin-producing Escherichia coli serotype O157","volume":"16","author":"Chart","year":"2000","journal-title":"World J Microbiol Biotechnol"},{"key":"R4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1365-2672.2003.01863.x","article-title":"The pathogenicity of strains of Salmonella paratyphi B and Salmonella java","volume":"94","author":"Chart","year":"2003","journal-title":"J Appl Microbiol"},{"key":"R5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(05)60470-9","article-title":"Salivary antibodies to lipopolysaccharide antigens of Escherichia coli serotype O157","volume":"352","author":"Chart","year":"1998","journal-title":"Lancet"},{"key":"R6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2672.1999.00766.x","article-title":"Serodiagnosis of infections caused by verocytotoxin-producing Escherichia coli","volume":"86","author":"Chart","year":"1999","journal-title":"J Appl Microbiol"},{"key":"R7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1128\/JCM.27.2.285-290.1989","article-title":"Serum antibodies to Escherichia coli serotype O157\u200a:\u200aH7 in patients with hemolytic uremic syndrome","volume":"27","author":"Chart","year":"1989","journal-title":"J Clin Microbiol"},{"key":"R8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1017\/S0950268800048986","article-title":"The serological relationship between Yersinia enterocolitica O9 and Escherichia coli O157 using sera from patients with yersiniosis and haemolytic uraemic syndrome","volume":"107","author":"Chart","year":"1991","journal-title":"Epidemiol Infect"},{"key":"R9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S0950268800049529","article-title":"The serological relationship between Escherichia coli O157 and Yersinia enterocolitica O9 using sera from patients with brucellosis","volume":"108","author":"Chart","year":"1992","journal-title":"Epidemiol Infect"},{"key":"R10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0888-0786(93)90044-Z","article-title":"Antigenic cross-reactions between Escherichia coli O157, Vibrio cholerae O1 Inaba and group N Salmonella","volume":"5","author":"Chart","year":"1993","journal-title":"Serodiag Immunother Inf Dis"},{"key":"R11","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1099\/0022-1317-51-12-1050","article-title":"Production of serum antibodies that recognise epitopes located on the R3 region of Escherichia coli core lipopolysaccharides in patients infected with strains of enterohaemorrhagic E. coli","volume":"51","author":"Chart","year":"2002a","journal-title":"J Med Microbiol"},{"key":"R12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1099\/0022-1317-51-6-522","article-title":"The kinetics of antibody production to antigens of Escherichia coli O157 in a pregnant woman with haemolytic uraemic syndrome","volume":"51","author":"Chart","year":"2002b","journal-title":"J Med Microbiol"},{"key":"R13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1099\/jmm.0.05126-0","article-title":"Analysis of saliva for antibodies to the LPS of Escherichia coli O157 in patients with serum antibodies to E. coli O157 LPS","volume":"52","author":"Chart","year":"2003","journal-title":"J Med Microbiol"},{"key":"R14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1365-2672.2004.02233.x","article-title":"The expression of an R3 lipopolysaccharide-core by pathotypes of Escherichia coli","volume":"96","author":"Chart","year":"2004","journal-title":"J Appl Microbiol"},{"key":"R15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1472-765X.2003.01391.x","article-title":"Human antibody responses to R3-core epitopes on the lipopolysaccharide of Escherichia coli O157","volume":"37","author":"Dalwai","year":"2003","journal-title":"Lett Appl Microbiol"},{"key":"R16","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1023\/A:1011072907877","article-title":"Evidence of persisting serum antibodies to Escherichia coli O157 lipopolysaccharide and Verocytotoxin in members of rural communities in England","volume":"16","author":"Evans","year":"2000","journal-title":"Eur J Epidemiol"},{"key":"R17","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/bmj.318.7185.684","article-title":"Haemolytic uraemic syndrome and E. coli O157 \u2013 prevention rests with sound public health measures","volume":"318","author":"Fitzpatrick","year":"1999","journal-title":"BMJ"},{"key":"R18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/S0950268804001979","article-title":"Disease burden in The Netherlands due to infections with Shiga toxin-producing Escherichia coli O157","volume":"132","author":"Havelaar","year":"2004","journal-title":"Epidemiol Infect"},{"key":"R19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1365-2958.1998.01063.x","article-title":"Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica","volume":"30","author":"Heinrichs","year":"1998","journal-title":"Mol Microbiol"},{"key":"R20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(99)02214-X","article-title":"Antibodies to lipopolysaccharides of Escherichia coli serogroups O5 and O165 in healthy adults","volume":"354","author":"Jenkins","year":"1999a","journal-title":"Lancet"},{"key":"R21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2672.1999.00695.x","article-title":"Serodiagnosis of infection with verocytotoxin-producing Escherichia coli serogroups","volume":"86","author":"Jenkins","year":"1999b","journal-title":"J Appl Microbiol"},{"key":"R22","first-page":"14","article-title":"Escherichia coli serogroup O26 \u2013 a new look at an old adversary","volume":"104","author":"Jenkins","year":"2008","journal-title":"J Appl Microbiol"},{"key":"R23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijmm.2005.06.009","article-title":"Enterohaemorrhagic Escherichia coli in human medicine","volume":"295","author":"Karch","year":"2005","journal-title":"Int J Med Microbiol"},{"key":"R24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/151.5.775","article-title":"The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli","volume":"151","author":"Karmali","year":"1985","journal-title":"J Infect Dis"},{"key":"R25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"R26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/adc.59.5.397","article-title":"Haemolytic uraemic syndrome","volume":"59","author":"Levin","year":"1984","journal-title":"Arch Dis Child"},{"key":"R27","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3201\/eid1104.040833","article-title":"Childhood hemolytic uremic syndrome, United Kingdom and Ireland","volume":"11","author":"Lynn","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"R28","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(98)01267-7","article-title":"Escherichia coli serotype O157\u200a:\u200aH7","volume":"352","author":"Mead","year":"1998","journal-title":"Lancet"},{"key":"R29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/clinids\/9.1.28","article-title":"Traditional enteropathogenic Escherichia coli of infantile diarrhea","volume":"9","author":"Robins-Browne","year":"1987","journal-title":"Rev Infect Dis"},{"key":"R30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268800050615","article-title":"A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome","volume":"110","author":"Rowe","year":"1993","journal-title":"Epidemiol Infect"},{"key":"R31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/infdis\/162.5.1069","article-title":"Properties of strains of Escherichia coli O26\u200a:\u200aH11 in relation to their enteropathogenic or enterohemorrhagic classification","volume":"162","author":"Scotland","year":"1990","journal-title":"J Infect Dis"},{"key":"R32","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"R33","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0950268800051013","article-title":"Vero cytotoxin-producing Escherichia coli , particularly serogroup O 157, associated with human infections in the United Kingdom: 1989\u201391","volume":"110","author":"Thomas","year":"1993","journal-title":"Epidemiol Infect"},{"key":"R34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268800001060","article-title":"Vero cytotoxin-producing Escherichia coli , particularly serogroup O157, associated with human infections in the United Kingdom: 1992\u20134","volume":"117","author":"Thomas","year":"1996","journal-title":"Epidemiol Infect"}],"container-title":["Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.2008\/003632-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T01:19:42Z","timestamp":1601255982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.2008\/003632-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,1]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11,1]]}},"URL":"https:\/\/doi.org\/10.1099\/jmm.0.2008\/003632-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725237530.793501515","asserted-by":"object"}]},"ISSN":["0022-2615","1473-5644"],"issn-type":[{"value":"0022-2615","type":"print"},{"value":"1473-5644","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,1]]}}}